BeStock  
Stocks › Biotechnology › CYTK

Cytokinetics CYTK

US equityMarket cap rank #1720Biotechnology
$50.78 −$0.68 (-1.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $52.48 +3.35%
Open$51.27
Prev close$51.46
Day range$50.60 – $53.45
Volume1.43M
Market cap$7.07B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership118.2%+0.94 pts vs. prior quarter
Institutions holding578+5 vs. prior quarter
Insider trades (recent)16 buys / 34 sellsNet selling
Short interest12.90% of floatDays to cover 14.2 · as of 30 Oct 2026
Short-sale volume share20.0%5-day average of daily volume

Short-sale volume as % of daily volume

11%21%30%40%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$10.10M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$10.4MSuper+$294.2KBig+$176.7KMid+$6.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 44.9% of shares outstanding.

Largest holders

  • BlackRock15.10%
  • T. Rowe Price Group, Inc.14.84%
  • State Street Global Advisors5.13%
  • Wellington Management Group4.98%
  • Vanguard Portfolio Management, LLC4.88%
  • Vanguard Capital Management, LLC4.50%
  • FMR3.61%
  • Avoro Capital Advisors LLC3.59%

By investor type

  • Mutual Fund86.42%
  • Hedge Fund18.60%
  • Public Company5.41%
  • Private Company2.94%
  • VC/PE Fund2.68%
  • Government Pension Fund0.94%
  • Sovereign Wealth Fund0.73%
  • Insurance Company0.42%

Reported short interest has risen from 11.74% to 12.90% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +946,790 15.1%
WCM Investment Management Mutual Fund 2026/Q3 +910,486 0.7%
Vaughan Nelson Investment Management, L.P. Mutual Fund 2026/Q3 +661,165 0.5%
State Street Global Advisors Mutual Fund 2026/Q3 +648,996 5.1%
BlackRock Mutual Fund 2026/Q3 +3,546,351 14.5%
Avoro Capital Advisors LLC Hedge Fund 2026/Q3 +1,666,666 3.6%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,569,283 14.8%
Bank of America Corporation Public Company 2026/Q3 +1,380,404 3.2%
Holocene Advisors, LP Hedge Fund 2026/Q3 +1,144,579 0.8%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +961,610 1.1%
Macquarie Investment Management Business Trust Mutual Fund 2026/Q3 +913,332 0.7%
Capital Research Mutual Fund 2026/Q3 +889,445 2.3%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +868,017 4.8%
State Street Global Advisors Mutual Fund 2026/Q3 +749,040 4.7%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +735,682 5.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
8 Nov 2026 B. Parshall Independent Director Open Market Disposition -5,000 $55.26 5,784
2 Nov 2026 Fady Malik Officer Derivative Exercise and Sale -3,500 $62.93 98,659
1 Nov 2026 Robert Blum Chief Executive Officer Derivative Exercise and Sale -7,500 $62.81 125,496
19 Oct 2026 Fady Malik Officer Derivative Exercise and Sale -3,500 $64.01 98,659
15 Oct 2026 Wendell Wierenga Independent Director Other Acquisition +97 $63.92 35,660
15 Oct 2026 Nancy Wysenski Independent Director Other Acquisition +97 $63.92 34,089
15 Oct 2026 John Henderson Independent Chairperson Other Acquisition +352 $63.92 78,795
15 Oct 2026 James Daly Independent Director Other Acquisition +195 $63.92 3,585
15 Oct 2026 Robert Harrington Independent Director Other Acquisition +195 $63.92 22,127
15 Oct 2026 Edward Kaye Independent Director Other Acquisition +195 $63.92 10,629
11 Oct 2026 Robert Blum Chief Executive Officer Derivative Exercise and Sale -7,500 $62.88 125,496
5 Oct 2026 Fady Malik Officer Derivative Exercise and Sale -3,500 $61.38 98,659
27 Sep 2026 Robert Blum Chief Executive Officer Derivative Exercise and Sale -7,500 $65.46 125,496
21 Sep 2026 Fady Malik Officer Derivative Exercise and Sale -3,500 $68.29 98,659
14 Sep 2026 Robert Blum Chief Executive Officer Open Market Disposition -97,926 $69.33 125,496
14 Sep 2026 Robert Landry Independent Director Open Market Disposition -1,000 $72.13 8,184
13 Sep 2026 Robert Blum Chief Executive Officer Other Acquisition +97,926 – 125,496
13 Sep 2026 Robert Blum Chief Executive Officer Other Disposition -99,276 – 125,496
13 Sep 2026 Robert Blum Chief Executive Officer Derivative Exercise and Sale -7,500 $73.44 125,496
10 Sep 2026 Robert Landry Independent Director Open Market Disposition -1,000 $74.66 9,184

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 17,929,635 12.9% 14.2
15 Oct 2026 18,628,116 13.4% 8.7
30 Sep 2026 19,333,243 13.9% 8.4
15 Sep 2026 17,481,383 12.6% 10.6
31 Aug 2026 17,442,378 12.5% 9.7
14 Aug 2026 16,323,712 11.7% 7.7

Discussion

No comments yet — be the first to weigh in on CYTK.

Sign in to join the discussion.

Scroll to Top